SPRO 8-K: Board change
Filed with the SEC on · accession 0001193125-26-455789
SPRO filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Patrick Vink, M.D. resigned from Spero Therapeutics' Board of Directors effective November 10, 2026, and the Board appointed William Ho, M.D., Ph.D. as a Class II director to fill the vacancy, effective the same date.
Key details
✦ Ask GOAX AI about this filing — what it means for SPRO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SPRO?
Click hereFrequently asked questions
What did SPRO file with the SEC on Nov 10, 2026?
SPRO filed a 8-K (Board change). Patrick Vink, M.D. resigned from Spero Therapeutics' Board of Directors effective November 10, 2026, and the Board appointed William Ho, M.D., Ph.D. as a Class II director to fill the vacancy, effective the same date.
What does a board change mean for SPRO stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other SPRO SEC filings
- 8-K · Executive departureOct 27, 2026
- EFFECT · SEC filingSep 10, 2026
- S-3 · Shelf registrationAug 28, 2026
- 8-K · Material agreementAug 28, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · Material agreementJul 14, 2026
- 8-K · SEC filingJun 25, 2026
- 8-K · Fda approvalJun 22, 2026
- 8-K · SEC filingMay 13, 2026
Get alerts when SPRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days